Movatterモバイル変換


[0]ホーム

URL:


WO2003035894A3 - Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample - Google Patents

Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
Download PDF

Info

Publication number
WO2003035894A3
WO2003035894A3PCT/US2002/034397US0234397WWO03035894A3WO 2003035894 A3WO2003035894 A3WO 2003035894A3US 0234397 WUS0234397 WUS 0234397WWO 03035894 A3WO03035894 A3WO 03035894A3
Authority
WO
WIPO (PCT)
Prior art keywords
cells
rare
detection
assay
blood
Prior art date
Application number
PCT/US2002/034397
Other languages
French (fr)
Other versions
WO2003035894A2 (en
WO2003035894A8 (en
Inventor
Shawn Mark O'hara
Daniel Zweitzig
Brad Foulk
Original Assignee
Immunivest Corp
Shawn Mark O'hara
Daniel Zweitzig
Brad Foulk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunivest Corp, Shawn Mark O'hara, Daniel Zweitzig, Brad FoulkfiledCriticalImmunivest Corp
Priority to AU2002360305ApriorityCriticalpatent/AU2002360305A1/en
Priority to CA002465274Aprioritypatent/CA2465274A1/en
Priority to EP02795554Aprioritypatent/EP1438398A2/en
Publication of WO2003035894A2publicationCriticalpatent/WO2003035894A2/en
Publication of WO2003035894A3publicationCriticalpatent/WO2003035894A3/en
Publication of WO2003035894A8publicationCriticalpatent/WO2003035894A8/en

Links

Classifications

Landscapes

Abstract

A highly sensitive assay is disclosed which utilizes a method for gene specific primed amplification of mRNA libraries from rare cells and rare transcripts found in blood. The assay allows detection of rare mRNA (10 copies/cell) found in 1 to 10 cells isolated through immunomagnetic enrichment. The assay is an improvement over multiplex PCR and allows efficient detection of rare coding sequences for circulating carcinoma cells in the blood. The methods are useful in profiling of cells isolated from tissues or body fluids and serves as an adjunct to clinical diagnosis of diverse carcinomas including early stage detection and classification of circulating tumor cells. Monitoring of nucleic acid and protein profiles of cells either in conventional or microarray formats, facilitates management of therapeutic intervention including staging, monitoring response to therapy, confirmation of remission and detection of regression.
PCT/US2002/0343972001-10-262002-10-28Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sampleWO2003035894A2 (en)

Priority Applications (3)

Application NumberPriority DateFiling DateTitle
AU2002360305AAU2002360305A1 (en)2001-10-262002-10-28Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
CA002465274ACA2465274A1 (en)2001-10-262002-10-28Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
EP02795554AEP1438398A2 (en)2001-10-262002-10-28Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample

Applications Claiming Priority (4)

Application NumberPriority DateFiling DateTitle
US33066901P2001-10-262001-10-26
US60/330,6692001-10-26
US36994502P2002-04-042002-04-04
US60/369,9452002-04-04

Publications (3)

Publication NumberPublication Date
WO2003035894A2 WO2003035894A2 (en)2003-05-01
WO2003035894A3true WO2003035894A3 (en)2003-12-04
WO2003035894A8 WO2003035894A8 (en)2004-06-03

Family

ID=26987390

Family Applications (2)

Application NumberTitlePriority DateFiling Date
PCT/US2002/034397WO2003035894A2 (en)2001-10-262002-10-28Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
PCT/US2002/034570WO2003035895A2 (en)2001-10-262002-10-28Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample

Family Applications After (1)

Application NumberTitlePriority DateFiling Date
PCT/US2002/034570WO2003035895A2 (en)2001-10-262002-10-28Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample

Country Status (9)

CountryLink
EP (2)EP1438419A2 (en)
JP (1)JP2005507997A (en)
KR (1)KR20040047971A (en)
CN (1)CN1610752A (en)
AU (1)AU2002360305A1 (en)
BR (1)BR0213520A (en)
CA (2)CA2465274A1 (en)
IL (1)IL161357A0 (en)
WO (2)WO2003035894A2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US8137912B2 (en)2006-06-142012-03-20The General Hospital CorporationMethods for the diagnosis of fetal abnormalities
US8168389B2 (en)2006-06-142012-05-01The General Hospital CorporationFetal cell analysis using sample splitting
US8195415B2 (en)2008-09-202012-06-05The Board Of Trustees Of The Leland Stanford Junior UniversityNoninvasive diagnosis of fetal aneuploidy by sequencing
US8921102B2 (en)2005-07-292014-12-30Gpb Scientific, LlcDevices and methods for enrichment and alteration of circulating tumor cells and other particles
US10591391B2 (en)2006-06-142020-03-17Verinata Health, Inc.Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US10704090B2 (en)2006-06-142020-07-07Verinata Health, Inc.Fetal aneuploidy detection by sequencing

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6913697B2 (en)2001-02-142005-07-05Science & Technology Corporation @ UnmNanostructured separation and analysis devices for biological membranes
US8980568B2 (en)2001-10-112015-03-17Aviva Biosciences CorporationMethods and compositions for detecting non-hematopoietic cells from a blood sample
US8986944B2 (en)2001-10-112015-03-24Aviva Biosciences CorporationMethods and compositions for separating rare cells from fluid samples
AU2003216175A1 (en)2002-02-042003-09-02Colorado School Of MinesLaminar flow-based separations of colloidal and cellular particles
CA2500392C (en)2002-09-272012-11-27The General Hospital CorporationMicrofluidic device for cell separation and uses thereof
EP1678327A4 (en)*2003-10-162007-10-10Genomic Health IncQrt-pcr assay system for gene expression profiling
US7332597B2 (en)2004-06-282008-02-19University Of Kentucky Research FoundationPrimers and probe to identify mycobacterium tuberculosis complex
ITBO20040420A1 (en)2004-07-072004-10-07Type S R L METAL CUTTING AND FORMING MACHINE
DE102005013261A1 (en)*2005-03-222006-09-28Adnagen Ag Reagent and method for preventing time-dependent expression in biological cells
US20070196820A1 (en)2005-04-052007-08-23Ravi KapurDevices and methods for enrichment and alteration of cells and other particles
DE102005029808A1 (en)*2005-06-272007-01-04Siemens Ag Support material, process for its preparation and use
ITBO20050481A1 (en)2005-07-192007-01-20Silicon Biosystems S R L METHOD AND APPARATUS FOR THE HANDLING AND / OR IDENTIFICATION OF PARTICLES
EP1930426A4 (en)2005-09-022009-04-29Toray Industries COMPOSITION AND METHOD FOR DIAGNOSIS OF KIDNEY CANCER AND EVALUATION OF VITAL PROGNOSIS OF A PATIENT WITH KIDNEY CANCER
US20070059683A1 (en)*2005-09-152007-03-15Tom BarberVeterinary diagnostic system
ES2886923T3 (en)2005-09-202021-12-21Menarini Silicon Biosystems Spa Methods and composition for generating single-sequence DNA probes, labeling of DNA probes, and the use of these probes
US9134237B2 (en)2005-09-202015-09-15Janssen Diagnotics, LLCHigh sensitivity multiparameter method for rare event analysis in a biological sample
ITBO20050646A1 (en)2005-10-262007-04-27Silicon Biosystem S R L METHOD AND APPARATUS FOR CHARACTERIZATION AND COUNTING OF PARTICLES
US8119976B2 (en)2007-07-032012-02-21Colorado School Of MinesOptical-based cell deformability
US9885644B2 (en)2006-01-102018-02-06Colorado School Of MinesDynamic viscoelasticity as a rapid single-cell biomarker
US9878326B2 (en)2007-09-262018-01-30Colorado School Of MinesFiber-focused diode-bar optical trapping for microfluidic manipulation
US9487812B2 (en)2012-02-172016-11-08Colorado School Of MinesOptical alignment deformation spectroscopy
ITTO20060226A1 (en)2006-03-272007-09-28Silicon Biosystem S P A METHOD AND APPARATUS FOR PROCESSING AND OR ANALYSIS AND OR SELECTION OF PARTICLES, IN PARTICULAR BIOLOGICAL PARTICLES
EP2008102A4 (en)*2006-04-182009-07-08Wellstat Biologics CorpDetection of proteins from circulating neoplastic cells
CN101583722A (en)2006-07-142009-11-18阿维瓦生物科学股份有限公司Methods and compositions for detecting rare cells from a biological sample
JP4926812B2 (en)*2007-02-012012-05-09シスメックス株式会社 Blood cell analyzer and body fluid analysis method
US10722250B2 (en)2007-09-042020-07-28Colorado School Of MinesMagnetic-field driven colloidal microbots, methods for forming and using the same
ITTO20070771A1 (en)2007-10-292009-04-30Silicon Biosystems Spa METHOD AND APPARATUS FOR IDENTIFICATION AND HANDLING OF PARTICLES
IT1391619B1 (en)2008-11-042012-01-11Silicon Biosystems Spa METHOD FOR THE IDENTIFICATION, SELECTION AND ANALYSIS OF TUMOR CELLS
US10895575B2 (en)2008-11-042021-01-19Menarini Silicon Biosystems S.P.A.Method for identification, selection and analysis of tumour cells
KR101936842B1 (en)2009-03-172019-01-10메나리니 실리콘 바이오시스템스 에스.피.에이.Microfluidic device for isolation of cells
JP5729904B2 (en)2009-06-022015-06-03キヤノン株式会社 Methods for preparing proteins, DNA, RNA from cells
CN102575244B (en)2009-09-172015-07-22Jsr株式会社 Dissociation method and dissociation agent of avidin and biotin derivative
CN102803490B (en)*2010-01-042015-03-25奇亚根盖瑟斯堡股份有限公司 Methods, compositions and kits for the recovery of nucleic acids or proteins from fixed tissue samples
WO2012034013A2 (en)2010-09-102012-03-15Bio-Rad Laboratories, Inc.Detection of rna-interacting regions in dna
CN102565404B (en)*2010-12-242014-04-16牛刚Kit for detecting free colorectal cancer cell markers in blood
CN102156164B (en)*2011-01-132012-12-12北京肿瘤医院Mass spectra identification method of nucleophosmin variable spliceosome and gastric cancer diagnostic reagent kit
CN102109525B (en)*2011-01-262013-10-16牛刚Kit for detecting free breast cancer cell marker in blood
EP2675913B1 (en)2011-02-152016-12-14Bio-Rad Laboratories, Inc.Detecting methylation in a subpopulation of genomic dna
US20120252038A1 (en)*2011-04-012012-10-04Chianese David ASteroid receptor assays
US8728987B2 (en)*2011-08-032014-05-20Bio-Rad Laboratories, Inc.Filtering small nucleic acids using permeabilized cells
ITTO20110990A1 (en)2011-10-282013-04-29Silicon Biosystems Spa METHOD AND APPARATUS FOR OPTICAL ANALYSIS OF LOW TEMPERATURE PARTICLES
ITBO20110766A1 (en)2011-12-282013-06-29Silicon Biosystems Spa DEVICES, EQUIPMENT, KITS AND METHOD FOR THE TREATMENT OF A BIOLOGICAL SAMPLE
WO2014067528A1 (en)*2012-10-292014-05-08Arcedi Biotech ApsImproved enrichment and detection of rare blood cells
WO2014145989A1 (en)*2013-03-152014-09-18Iris International, Inc.Method and composition for staining and processing a urine sample
US9857361B2 (en)2013-03-152018-01-02Iris International, Inc.Flowcell, sheath fluid, and autofocus systems and methods for particle analysis in urine samples
US9771571B2 (en)2014-02-282017-09-26Gen-Probe IncorporatedMethod of isolating nucleic acid from specimens in liquid-based cytology preservatives containing formaldehyde
USRE48665E1 (en)*2014-02-282021-08-03Gen-Probe IncorporatedMethod of isolating nucleic acid from specimens in liquid-based cytology preservatives containing formaldehyde
US9771572B2 (en)2014-02-282017-09-26Gen-Probe IncorporatedMethod of isolating nucleic acid from specimens in liquid-based cytology preservatives containing formaldehyde
JP2014158468A (en)*2014-03-052014-09-04Clinical Genomics Pty LtdDetection method
WO2016130704A2 (en)*2015-02-102016-08-18Illumina, Inc.Methods and compositions for analyzing cellular components
US11168351B2 (en)2015-03-052021-11-09Streck, Inc.Stabilization of nucleic acids in urine
US20170145475A1 (en)2015-11-202017-05-25Streck, Inc.Single spin process for blood plasma separation and plasma composition including preservative
US10282588B2 (en)*2016-06-092019-05-07Siemens Healthcare GmbhImage-based tumor phenotyping with machine learning from synthetic data
CA3079415A1 (en)2017-10-192019-04-25Streck, Inc.Compositions for hemolysis and coagulation regulation and stabilization of extracellular vesicles
CN110456034B (en)*2018-05-072022-07-22上海市第十人民医院 A kind of detection method of circulating tumor cells
CN109402240B (en)*2019-01-082020-08-25圣湘生物科技股份有限公司Nucleic acid releasing agent, nucleic acid PCR amplification method and PCR amplification kit
WO2023080601A1 (en)*2021-11-052023-05-11고려대학교 세종산학협력단Disease diagnosis method and device using machine learning-based lens-free shadow imaging technology
KR102707636B1 (en)*2021-11-052024-09-20고려대학교 세종산학협력단Device and method of leukemia diagnosis using machine learning-based lens-free shadow imaging technology
JP2023103711A (en)*2022-01-142023-07-27株式会社島津製作所 Electrophoresis system, electrophoresis apparatus, electrophoresis analysis method, and electrophoresis analysis program
CN116042772B (en)*2023-02-102025-07-29上海立闻生物科技有限公司Methods and kits for whole transcriptome sequencing of small amounts of tumor cells from fresh samples

Citations (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4929556A (en)*1986-02-061990-05-29The Dow Chemical CompanyEnzyme immobilization with polysulfonium salts
US5346994A (en)*1992-01-281994-09-13Piotr ChomczynskiShelf-stable product and process for isolating RNA, DNA and proteins
US6156564A (en)*1996-06-072000-12-05The United States Of America As Represented By The Department Of Health And Human ServicesCellular apoptosis susceptibility protein (CSP) and antisense CSP
US6329179B1 (en)*1996-03-262001-12-11Oncomedx, Inc.Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US6358697B2 (en)*1999-04-212002-03-19Children's Hospital Medical CenterIntracellular pharmaceutical targeting
US6365362B1 (en)*1998-02-122002-04-02Immunivest CorporationMethods and reagents for the rapid and efficient isolation of circulating cancer cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP0951541B1 (en)*1995-07-312005-11-30Urocor, Inc.Biomarkers and targets for diagnosis, prognosis and management of prostate disease
US6156515A (en)*1999-02-092000-12-05Urocor, Inc.Prostate-specific gene for diagnosis, prognosis and management of prostate cancer

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4929556A (en)*1986-02-061990-05-29The Dow Chemical CompanyEnzyme immobilization with polysulfonium salts
US5346994A (en)*1992-01-281994-09-13Piotr ChomczynskiShelf-stable product and process for isolating RNA, DNA and proteins
US6329179B1 (en)*1996-03-262001-12-11Oncomedx, Inc.Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US6156564A (en)*1996-06-072000-12-05The United States Of America As Represented By The Department Of Health And Human ServicesCellular apoptosis susceptibility protein (CSP) and antisense CSP
US6365362B1 (en)*1998-02-122002-04-02Immunivest CorporationMethods and reagents for the rapid and efficient isolation of circulating cancer cells
US6358697B2 (en)*1999-04-212002-03-19Children's Hospital Medical CenterIntracellular pharmaceutical targeting

Cited By (22)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US8921102B2 (en)2005-07-292014-12-30Gpb Scientific, LlcDevices and methods for enrichment and alteration of circulating tumor cells and other particles
US11674176B2 (en)2006-06-142023-06-13Verinata Health, IncFetal aneuploidy detection by sequencing
US9273355B2 (en)2006-06-142016-03-01The General Hospital CorporationRare cell analysis using sample splitting and DNA tags
US10591391B2 (en)2006-06-142020-03-17Verinata Health, Inc.Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US8372584B2 (en)2006-06-142013-02-12The General Hospital CorporationRare cell analysis using sample splitting and DNA tags
US8137912B2 (en)2006-06-142012-03-20The General Hospital CorporationMethods for the diagnosis of fetal abnormalities
US8168389B2 (en)2006-06-142012-05-01The General Hospital CorporationFetal cell analysis using sample splitting
US9017942B2 (en)2006-06-142015-04-28The General Hospital CorporationRare cell analysis using sample splitting and DNA tags
US11781187B2 (en)2006-06-142023-10-10The General Hospital CorporationRare cell analysis using sample splitting and DNA tags
US9347100B2 (en)2006-06-142016-05-24Gpb Scientific, LlcRare cell analysis using sample splitting and DNA tags
US11261492B2 (en)2006-06-142022-03-01The General Hospital CorporationMethods for the diagnosis of fetal abnormalities
US10704090B2 (en)2006-06-142020-07-07Verinata Health, Inc.Fetal aneuploidy detection by sequencing
US10041119B2 (en)2006-06-142018-08-07Verinata Health, Inc.Methods for the diagnosis of fetal abnormalities
US10155984B2 (en)2006-06-142018-12-18The General Hospital CorporationRare cell analysis using sample splitting and DNA tags
US10435751B2 (en)2006-06-142019-10-08Verinata Health, Inc.Methods for the diagnosis of fetal abnormalities
US8682594B2 (en)2008-09-202014-03-25The Board Of Trustees Of The Leland Stanford Junior UniversityNoninvasive diagnosis of fetal aneuploidy by sequencing
US10669585B2 (en)2008-09-202020-06-02The Board Of Trustees Of The Leland Stanford Junior UniversityNoninvasive diagnosis of fetal aneuploidy by sequencing
US9404157B2 (en)2008-09-202016-08-02The Board Of Trustees Of The Leland Stanford Junior UniversityNoninvasive diagnosis of fetal aneuploidy by sequencing
US9353414B2 (en)2008-09-202016-05-31The Board Of Trustees Of The Leland Stanford Junior UniversityNoninvasive diagnosis of fetal aneuploidy by sequencing
US8296076B2 (en)2008-09-202012-10-23The Board Of Trustees Of The Leland Stanford Junior UniversityNoninvasive diagnosis of fetal aneuoploidy by sequencing
US8195415B2 (en)2008-09-202012-06-05The Board Of Trustees Of The Leland Stanford Junior UniversityNoninvasive diagnosis of fetal aneuploidy by sequencing
US12054777B2 (en)2008-09-202024-08-06The Board Of Trustees Of The Leland Standford Junior UniversityNoninvasive diagnosis of fetal aneuploidy by sequencing

Also Published As

Publication numberPublication date
WO2003035895A2 (en)2003-05-01
CA2465288A1 (en)2003-05-01
JP2005507997A (en)2005-03-24
AU2002360305A1 (en)2003-05-06
EP1438398A2 (en)2004-07-21
WO2003035894A2 (en)2003-05-01
WO2003035894A8 (en)2004-06-03
CN1610752A (en)2005-04-27
BR0213520A (en)2006-05-23
EP1438419A2 (en)2004-07-21
CA2465274A1 (en)2003-05-01
KR20040047971A (en)2004-06-05
IL161357A0 (en)2004-09-27
WO2003035895A3 (en)2004-01-08

Similar Documents

PublicationPublication DateTitle
WO2003035894A8 (en)Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
US20230366034A1 (en)Compositions and methods for diagnosing lung cancers using gene expression profiles
Gläser et al.Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study.
EP1871912B1 (en)Method for determining DNA methylation in blood or urine samples
AU767983B2 (en)Methods for detecting nucleic acids indicative of cancer
CA2455731A1 (en)Methods for evaluating pathologic conditions using extracellular rna
JP7626797B2 (en) Detection of microsatellite instability
EP2357255A2 (en)Assay for methylation in the GST-Pi gene
WO2002079411A3 (en)Microarray gene expression profiling in clear cell renal cell carcinoma: prognosis and drug target identification
Takano et al.Quantitative measurement of thyroglobulin mRNA in peripheral blood of patients after total thyroidectomy
US20100233722A1 (en)Methods for determining the biological effect and/or activity of r pharmaceutical compositions based on their effect on the methylation status of the DNA
NO20032697D0 (en) Test strip assay system and assay method for detection and / or determination of specific nucleic acid sequences
CN116219020B (en)Methylation reference gene and application thereof
EP2808397A2 (en)Method for obtaining information on colon cancer and marker and kit for obtaining information on colon cancer
CA2462932A1 (en)Method for the detection of cytosine methylations in immobilized dna samples
CA2451483A1 (en)Methods for detecting and monitoring cox-2 rna in plasma and serum
WO1996021042A3 (en)Primers for the pcr amplification of metastatic sequences
US20080286784A1 (en)Method for Detection of DNA Methyltransferase RNA in Plasma and Serum
CN100371459C (en)Kit with fluorescent quantitative RT-PCR detection technique used for cell keratin 19(Ck19)mRNA
JP6269493B2 (en) Method for acquiring information on brain tumor, and marker and kit for acquiring information on brain tumor
CA2172142A1 (en)Primers and probes for the amplification and detection of cmv nucleic acid
RU2003125486A (en) METHOD FOR EARLY DIAGNOSIS OF DISEASES ASSOCIATED WITH DISTURBANCE OF FUNCTIONING OF THE CELL GENETIC APPARATUS
US20100159464A1 (en)Method for Detection of DNA Methyltransferase RNA in Plasma and Serum
Singhal et al.Current status of cell-free DNA in head and neck cancer management
CN115786503B (en)DNA methylation marker combination and kit for early screening of gastric cancer

Legal Events

DateCodeTitleDescription
AKDesignated states

Kind code of ref document:A2

Designated state(s):AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

ALDesignated countries for regional patents

Kind code of ref document:A2

Designated state(s):GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121Ep: the epo has been informed by wipo that ep was designated in this application
WWEWipo information: entry into national phase

Ref document number:2002795554

Country of ref document:EP

WWEWipo information: entry into national phase

Ref document number:2003538394

Country of ref document:JP

Ref document number:2465274

Country of ref document:CA

CFPCorrected version of a pamphlet front page
CR1Correction of entry in section i

Free format text:IN PCT GAZETTE 18/2003 UNDER (72, 75) REPLACE "[-/US]" BY "[US/US]"; ADD "DECLARATION UNDER RULE 4.17: - OF INVENTORSHIP (RULE 4.17(IV)) FOR US ONLY."

WWPWipo information: published in national office

Ref document number:2002795554

Country of ref document:EP

WWWWipo information: withdrawn in national office

Ref document number:2002795554

Country of ref document:EP


[8]ページ先頭

©2009-2025 Movatter.jp